Abstract

Epilepsy is characterized by highly abnormal synchronous discharge of brain neurons, and ion channels are fundamental in the generation and modulation of neural excitability. Considering that abnormal methylation can either activate or repress genes, this study was designed to explore the DNA methylation signature of pathogenic genes encoding ion channels in temporal lobe epilepsy (TLE). In total, 38 TLE patients and 38 healthy controls were enrolled in the study, and genomic DNA and total protein of the lymphocytes were extracted from peripheral blood samples to assess methylation and protein levels. The DNA methylation levels of all 12 genes examined were significantly lower in the TLE group than in the control group. After false-positive correction, 83.3% (10/12) of these genes, namely, gamma-aminobutyric acid type A receptor subunit beta1 (GABRB1), gamma-aminobutyric acid type A receptor subunit beta2 (GABRB2), gamma-aminobutyric acid type A receptor subunit beta1 (GABRB3), glutamate ionotropic receptor NMDA type subunit 1 (GRIN1), glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A), glutamate ionotropic receptor NMDA type subunit 2B (GRIN2B), hyperpolarization activated cyclic nucleotide gated potassium channel 1 (HCN1), potassium voltage-gated channel subfamily A member 2 (KCNA2), potassium voltage-gated channel subfamily B member 1 (KCNB1), and potassium sodium-activated channel subfamily T member 1 (KCNT1), were still differentially expressed. Among these ion channels, HCN1 and KCNA2 were selected to evaluate the effects of DNA methylation, and the levels of these proteins were inversely upregulated in the TLE group compared to the control group. As the genes identified as having differential methylation levels are involved in both excitatory and inhibitory ion channels, this study observed by binary logistic regression that hypermethylated GARAB1 was an independent risk factor for TLE, indicating that the overwhelming effect of ion channels on TLE is probably inhibitory from the perspective of DNA methylation. All these findings support the involvement of DNA methylation in TLE pathologies, but the mechanisms need to be further investigated.

Highlights

  • Temporal lobe epilepsy (TLE) is the most common form of human epilepsy and has a high chance of becoming medically intractable

  • Five of them, sodium voltage-gated channel alpha subunit 2 (SCN2A), glutamate ionotropic receptor NMDA type subunit 2D (GRIN2D), SCN1A, gamma-aminobutyric acid type A receptor subunit alpha1 (GABRA1), and gamma-aminobutyric acid type A receptor subunit gamma2 (GABRG2), were omitted from further testing because no CpG islands were found proximal to their promoters, indicating that genetic regulation of these genes is not modulated by methylation

  • The DNA methylation levels of all tested epilepsyrelated ion-channel genes were significantly downregulated in the temporal lobe epilepsy (TLE) group compared to the control group

Read more

Summary

Introduction

Temporal lobe epilepsy (TLE) is the most common form of human epilepsy and has a high chance of becoming medically intractable. DNA methylation is a major epigenetic modification that adds a methyl group to the fifth carbon of cytosine to form 5-methylcytosine; when present within cytosine-phosphateG (CpG) islands proximal to promoters, such modification downregulates genes via transcriptional silencing [4]. As it can be inherited by cell division, DNA methylation plays a crucial role in genetic regulation, with important implications for normal biology and disease [5]. The status of DNA methylation can predict the risk of drug resistance in TLE patients [7] All this evidence supports the involvement of DNA methylation in seizure susceptibility and maintenance of the disorder

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.